These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26586008)

  • 1. Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats.
    Wisniewski MS; Carvalho-Silva M; Gomes LM; Zapelini HG; Schuck PF; Ferreira GC; Scaini G; Streck EL
    Metab Brain Dis; 2016 Apr; 31(2):377-83. PubMed ID: 26586008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.
    Taschetto L; Scaini G; Zapelini HG; Ramos ÂC; Strapazzon G; Andrade VM; Réus GZ; Michels M; Dal-Pizzol F; Quevedo J; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Oct; 32(5):1507-1518. PubMed ID: 28550500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters.
    Rabelo F; Lemos IDS; Dal Toé CP; Casagrande DD; Freitas MLS; Quadra MR; Lima IR; Generoso JS; Michels M; Silveira PCL; Pizzol FD; Streck EL
    Metab Brain Dis; 2023 Jun; 38(5):1573-1579. PubMed ID: 36897514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
    Scaini G; Comim CM; Oliveira GM; Pasquali MA; Quevedo J; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Bogo MR; Streck EL
    J Inherit Metab Dis; 2013 Sep; 36(5):721-30. PubMed ID: 23109061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.
    Scaini G; Morais MO; Furlanetto CB; Kist LW; Pereira TC; Schuck PF; Ferreira GC; Pasquali MA; Gelain DP; Moreira JC; Bogo MR; Streck EL
    Neurochem Res; 2015 May; 40(5):885-93. PubMed ID: 25681161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
    Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
    Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Intracerebral Administration of α-Ketoisocaproic Acid to Neonate Rats Disrupts Brain Redox Homeostasis and Promotes Neuronal Death, Glial Reactivity, and Myelination Injury.
    Zemniaçak ÂB; Ribeiro RT; Pinheiro CV; de Azevedo Cunha S; Tavares TQ; Castro ET; Leipnitz G; Wajner M; Amaral AU
    Mol Neurobiol; 2024 May; 61(5):2496-2513. PubMed ID: 37910283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic effect of α-ketoisocaproic acid: in vivo and in vitro studies.
    Farias HR; Gabriel JR; Cecconi ML; Lemos IS; de Rezende VL; Wessler LB; Duarte MB; Scaini G; de Oliveira J; Streck EL
    Metab Brain Dis; 2021 Jan; 36(1):185-192. PubMed ID: 33034842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain.
    Amaral AU; Leipnitz G; Fernandes CG; Seminotti B; Schuck PF; Wajner M
    Brain Res; 2010 Apr; 1324():75-84. PubMed ID: 20153737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.
    Scaini G; Tonon T; de Souza CFM; Schuk PF; Ferreira GC; Neto JS; Amorin T; Schwartz IVD; Streck EL
    Mol Neurobiol; 2017 Sep; 54(7):5709-5719. PubMed ID: 27660262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats.
    de Castro Vasques V; de Boer MA; Diligenti F; Brinco F; Mallmann F; Mello CF; Wajner M
    Pharmacol Biochem Behav; 2004 Jan; 77(1):183-90. PubMed ID: 14724056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.
    Scaini G; Mello-Santos LM; Furlanetto CB; Jeremias IC; Mina F; Schuck PF; Ferreira GC; Kist LW; Pereira TC; Bogo MR; Streck EL
    Mol Neurobiol; 2013 Dec; 48(3):581-9. PubMed ID: 23559405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
    Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
    Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
    Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
    Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
    Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
    Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
    Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
    Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.